Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Women suffering from endometriosis and/or adenomyosis may also suffer from infertility. GnRH
agonist injection could improve implantation and therefore increase the pregnancy rate in
these patients. This study was designed to evaluate effects of the additional of GnRH agonist
(single or 2 doses) to the routine oestrogens and progestins use as support before Frozen
Embryon Transfer as compared to oestrogens and progestins only.